Titre |
Biotechnology Development
|
Dates |
19.10.2023, 13:00 - 16:15, and 20.10.2023, 08:30-11:45 and 13:30-16:30 |
Lang |
Workshop language is English |
Organisateur(s)/trice(s) |
Flora Juan, LightChainBio (LCB) |
Intervenant-e-s |
Nicolas Fischer (NF), Walter Ferlin (WF), Sara Majocchi (SM), Giovanni Magistrelli (GM), Ulla Ravn (UR), Franck Gueneau (FG), Eric Hatterer (EH), Adeline Lesnier (AL), Yves Poitevin (YP), Christophe Guillamo (CG), Xavier Chauchet (XC), Jenna Salti (JS), Stéphane Moutel (SM), Flora Juan (FJ)
|
Description |
• Overview of the steps for drug development (90', NF, WF) • Therapeutic antibody formats and discovery platforms (45', SM) • Toolbox to streamline the identification of Antibody Drug Candidate (45', GM) • Antibody discovery using display technologies (45', UR, FG) • Preclinical drug development: in vitro and in vivo pharmacology (45', EH) • Introduction to bioanalysis and clinical sample testing (45', AL) • Manufacturing of bispecific antibodies (45', YP, CG) • Development of a bispecific antibody for cancer therapy (45', XC) • Supporting Biotechs: the role of QA (30', JS) • Supporting Biotechs: the role of Project Management (30', SM, FJ) • Visit of LCB facilities (60') |
Programme |
Time
|
Topic
|
DAte
|
Time
|
Speaker
|
60’ / 90’
|
Overview of the steps for drug development
|
Thursday
Oct. 19th, PM
|
13:00-14:30
|
Nicolas Fischer
& Walter Ferlin
|
Coffee Break
|
15 min break
|
45’
|
Therapeutic antibody formats and discovery platforms
|
14:45-15:30
|
Sara Majocchi
|
45’
|
Toolbox to streamline the identification of Antibody Drug Candidate
|
15:30-16:15
|
Giovanni Magistrelli
|
45’
|
Antibody discovery using display technologies
|
Friday
Oct. 20th, AM
|
08:30-09:15
|
Ulla Ravn
& Franck Gueneau
|
45’
|
Preclinical drug development: in vitro and in vivo pharmacology
|
09:15-10:00
|
Eric Hatterer
|
Coffee Break
|
| |
Lieu |
@LightChainBio facilities (LCB), in Plan-Les-Ouates
|
Crédits |
1.5 |
Information |
|
Places |
20 |
Délai d'inscription |
12.10.2023 |